Narrative update of clinical trials with antihypertensive drugs in children and adolescents
To date, our knowledge on antihypertensive pharmacological treatment in children and adolescents is still limited because there are few randomized clinical trials (CTs), hampering appropriate management. The objective was to perform a narrative review of the most relevant aspects of clinical trials...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
21 November 2022
|
| In: |
Frontiers in Cardiovascular Medicine
Year: 2022, Volume: 9, Pages: 1-12 |
| ISSN: | 2297-055X |
| DOI: | 10.3389/fcvm.2022.1042190 |
| Online Access: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.3389/fcvm.2022.1042190 Verlag, lizenzpflichtig, Volltext: https://www.frontiersin.org/articles/10.3389/fcvm.2022.1042190 |
| Author Notes: | Josep Redon, Tomas Seeman, Dénes Pall, Lagle Suurorg, Konstantinos Kamperis, Serap Erdine, Elke Wühl and Giuseppe Mancia |
| Summary: | To date, our knowledge on antihypertensive pharmacological treatment in children and adolescents is still limited because there are few randomized clinical trials (CTs), hampering appropriate management. The objective was to perform a narrative review of the most relevant aspects of clinical trials carried out in primary and secondary hypertension. |
|---|---|
| Item Description: | Gesehen am 09.11.2023 |
| Physical Description: | Online Resource |
| ISSN: | 2297-055X |
| DOI: | 10.3389/fcvm.2022.1042190 |